At a glance
ClinicalIndex Comparison RecordN/ACompleted· 279 enrolled
Drug / intervention
Propylene Glycol, 0.6% eye drops +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Clinical Outcomes Following Treatment With Systane® Balance in Dry Eye Subjects With Lipid Deficiency
In Brief
A clinical study evaluating Propylene Glycol, 0.6% eye drops and Preservative-free 0.9% Saline solution for Dry Eye. Completed, enrolled 279 participants.
Detailed Summary
The purpose of this study is to demonstrate the superior efficacy of Systane® Balance over Preservative-Free 0.9% Saline following 35 days of QID (4 times a day) dosing in treating dry eye subjects with lipid deficiency.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDry Eye
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartFeb 2014
Primary CompletionJan 2015
TodayJul 2026
First PostedOct 22, 2013
Enrollment StartFeb 1, 2014
Primary CompletionJan 1, 2015
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 12.7 years ago
Interventions
Propylene Glycol, 0.6% eye dropsdrug
Commercially available eye drops used during Treatment Phase
Preservative-free 0.9% Saline solutiondrug
Commercially available solution used as Run-in (1 drop in each eye 4 times a day for 15 days) and during Treatment Phase